EAM Investors’s Teladoc Health TDOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
Sell
-7,283
Closed -$1.39M 351
2020
Q2
$1.39M Sell
7,283
-18,285
-72% -$3.2M 0.31% 159
2020
Q1
$3.96M Buy
+25,568
New +$2.97M 1.23% 3
2018
Q4
Sell
-42,444
Closed -$3.67M 320
2018
Q3
$3.67M Sell
42,444
-3,226
-7% -$230K 0.54% 45
2018
Q2
$2.65M Sell
45,670
-17,478
-28% -$854K 0.42% 121
2018
Q1
$2.54M Sell
63,148
-14,878
-19% -$562K 0.42% 121
2017
Q4
$2.72M Sell
78,026
-48,824
-38% -$1.62M 0.49% 67
2017
Q3
$4.21M Sell
126,850
-12,460
-9% -$409K 0.56% 47
2017
Q2
$4.83M Sell
139,310
-44,050
-24% -$1.28M 0.8% 9
2017
Q1
$4.58M Buy
+183,360
New +$3.81M 0.72% 11

Other funds holding TDOC

EAM Investors's TDOC Position: Q3 2020 in Review

EAM Investors sold out of Teladoc Health (TDOC) in Q3 2020, closing a stake of 7,283 shares — an estimated $1.39M sold.

EAM Investors first reported a position in TDOC in Q1 2017 and held it in 9 quarters. The position peaked at $4.83M in Q2 2017. 743 funds tracked by Wall St. Rank hold TDOC as of Q3 2020.

  • EAM Investors reported no remaining Teladoc Health position as of Q3 2020 after selling out during the quarter.
  • EAM Investors sold 7,283 Teladoc Health shares in Q3 2020, an estimated $1.39M.
  • EAM Investors first reported a position in Teladoc Health in Q1 2017 and held it in 9 quarters.
  • EAM Investors's Teladoc Health position peaked at $4.83M in Q2 2017.
  • 743 funds tracked by Wall St. Rank held Teladoc Health as of Q3 2020.

Based on EAM Investors's 13F filing for Q3 2020, filed 13 Nov 2020.